| Full Name | Kevin Hill |
|---|---|
| Gender | Male |
| Speciality | Anesthesiologist Assistant |
| Location | 4235 Secor Rd, Toledo, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891403291 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | 75000116A (Indiana) | Primary |
| Entity Name | Associated Anesthesiologists Of Fort Wayne, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538159140 PECOS PAC ID: 2264412444 Enrollment ID: O20040720001562 |
News Archive
A new survey from the American Association of Diabetes Educators found that Medicare's Competitive Bidding Program significantly reduced beneficiary choice and access to commonly used diabetes testing supplies.
Patients with a specific type of oesophageal cancer survived longer when they were given the latest lung cancer drug, according to trial results being presented at the National Cancer Research Institute (NCRI) Cancer Conference today (Wednesday).
New peer-reviewed research published today in the Harm Reduction Journal shows that flavors play a critical role in attracting - and retaining - smokers into the vaping category, directly contributing to tobacco harm reduction.
A novel, intelligent theranostic agent for precise tumor diagnosis and therapy has been developed that remains as small molecules while circulating in the bloodstream, can then self-assemble into larger nanostructures in the tumor, and be activated by the tumor microenvironment for therapy guided by photoacoustic imaging.
Curis, Inc. a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that its collaborator Genentech, a member of the Roche Group, has initiated a Phase II clinical trial of GDC-0449, an orally-administered small molecule Hedgehog Pathway Inhibitor, as a single-agent therapy for patients with operable basal cell carcinoma (BCC).
› Verified 9 days ago
| Entity Name | U S Anesthesia Partners Of Kentucky Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144901042 PECOS PAC ID: 9335502996 Enrollment ID: O20230912003685 |
News Archive
A new survey from the American Association of Diabetes Educators found that Medicare's Competitive Bidding Program significantly reduced beneficiary choice and access to commonly used diabetes testing supplies.
Patients with a specific type of oesophageal cancer survived longer when they were given the latest lung cancer drug, according to trial results being presented at the National Cancer Research Institute (NCRI) Cancer Conference today (Wednesday).
New peer-reviewed research published today in the Harm Reduction Journal shows that flavors play a critical role in attracting - and retaining - smokers into the vaping category, directly contributing to tobacco harm reduction.
A novel, intelligent theranostic agent for precise tumor diagnosis and therapy has been developed that remains as small molecules while circulating in the bloodstream, can then self-assemble into larger nanostructures in the tumor, and be activated by the tumor microenvironment for therapy guided by photoacoustic imaging.
Curis, Inc. a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that its collaborator Genentech, a member of the Roche Group, has initiated a Phase II clinical trial of GDC-0449, an orally-administered small molecule Hedgehog Pathway Inhibitor, as a single-agent therapy for patients with operable basal cell carcinoma (BCC).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kevin Hill, AA 12851 Sweitzer Rd, Carleton, MI 48117-9230 Ph: (734) 301-6287 | Kevin Hill, AA 4235 Secor Rd, Toledo, OH 43623-4299 Ph: (419) 473-3561 |
News Archive
A new survey from the American Association of Diabetes Educators found that Medicare's Competitive Bidding Program significantly reduced beneficiary choice and access to commonly used diabetes testing supplies.
Patients with a specific type of oesophageal cancer survived longer when they were given the latest lung cancer drug, according to trial results being presented at the National Cancer Research Institute (NCRI) Cancer Conference today (Wednesday).
New peer-reviewed research published today in the Harm Reduction Journal shows that flavors play a critical role in attracting - and retaining - smokers into the vaping category, directly contributing to tobacco harm reduction.
A novel, intelligent theranostic agent for precise tumor diagnosis and therapy has been developed that remains as small molecules while circulating in the bloodstream, can then self-assemble into larger nanostructures in the tumor, and be activated by the tumor microenvironment for therapy guided by photoacoustic imaging.
Curis, Inc. a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that its collaborator Genentech, a member of the Roche Group, has initiated a Phase II clinical trial of GDC-0449, an orally-administered small molecule Hedgehog Pathway Inhibitor, as a single-agent therapy for patients with operable basal cell carcinoma (BCC).
› Verified 9 days ago
Joshua Lynn Jay, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 3000 Arlington Ave, Toledo, OH 43614 Phone: 419-383-3556 | |
Kera Sparks, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 4235 Secor Rd, Toledo, OH 43623 Phone: 419-473-3561 | |
Andrew Mccray, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 3000 Arlington Ave, Toledo, OH 43614 Phone: 419-383-4000 | |
Brienne N Seekford, CAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 3000 Arlington Ave, Toledo, OH 43614 Phone: 419-383-3888 Fax: 419-383-2860 | |
Jonathan Daniel Cox, AA-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 3000 Arlington Ave, Mailstop #1137, Toledo, OH 43614 Phone: 419-383-3556 Fax: 419-383-3550 | |
Mr. Jacob Kanjuparamban, A.A. Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 3000 Arlington Ave, Toledo, OH 43614 Phone: 419-383-3556 Fax: 419-383-3550 | |
Mr. Patrick Bolger, A.A. Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 3000 Arlington Ave, Toledo, OH 43614 Phone: 419-383-3556 Fax: 419-353-3550 |